Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years

J Antimicrob Chemother. 2007 Aug;60(2):356-62. doi: 10.1093/jac/dkm210. Epub 2007 Jun 11.

Abstract

Objectives: Provision of outpatient parenteral antimicrobial therapy (OPAT) is an evolving field, facilitating discharge from hospital for selected patients with serious infections. We report on a large OPAT cohort focusing on the practice of supervised parenteral antibiotic administration in the community by patients and relatives, which we collectively term 'self-administration'. To distinguish between healthcare professional OPAT and self-administered OPAT, we have coined the terms H-OPAT and S-OPAT, respectively.

Patients and methods: We analysed data on 2059 OPAT episodes collected prospectively over a 13 year time period from 1993 to 2005.

Results: Clinical diagnosis, microbiology and antibiotics in this OPAT series are comparable to those previously reported. We identified no excess complications or hospital re-admissions in the S-OPAT group compared with the H-OPAT group.

Conclusions: Self-administration of intravenous antimicrobial therapy, in selected patients under the supervision of a specialist team, is a safe and feasible strategy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Ambulatory Care
  • Anti-Infective Agents / adverse effects*
  • Anti-Infective Agents / therapeutic use*
  • Catheters, Indwelling
  • Cohort Studies
  • Data Collection
  • Female
  • Home Infusion Therapy*
  • Humans
  • Infections / drug therapy
  • Infections / microbiology
  • Infusions, Parenteral
  • Male
  • Outpatients
  • Retrospective Studies

Substances

  • Anti-Infective Agents